Phocas Financial Corp. Chembio Diagnostics, Inc. Transaction History

Phocas Financial Corp.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 25, 2022	SELL	$0.66 - $1.23 $13,200 - $24,600	-20,000 Reduced 66.67%	10,000 $8,000
Q1 2021 Jun 22, 2021	BUY	$3.4 - $7.97 $34,000 - $79,700	10,000 Added 50.0%	30,000 $105,000
Q3 2017 Nov 17, 2017	BUY	$5.85 - $6.2 $117,000 - $124,000	20,000	20,000 $0

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.